Rithm Capital Corp. (RITM) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-03-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2024-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2024-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2024-03-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 4.08B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | (m) | |
| Interest expense · reported / estimated | 1.53B USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | (m) | $4.08B | (m) | (m) | $1.53B | (m) | (m) | (m) | Reported |
| 2023-12-31 | (m) | $3.72B | (m) | (m) | $1.42B | (m) | (m) | (m) | Reported |
| 2023-09-30 | (m) | $3.68B | (m) | (m) | $1.30B | (m) | (m) | (m) | Reported |
| 2023-06-30 | (m) | $3.50B | (m) | (m) | $1.14B | (m) | (m) | (m) | Reported |
| 2023-03-31 | (m) | $3.78B | (m) | (m) | $961.24M | (m) | (m) | (m) | Reported |
| 2022-12-31 | (m) | $4.73B | (m) | (m) | $791.00M | (m) | (m) | (m) | Reported |
| 2022-09-30 | (m) | $5.06B | (m) | (m) | $649.69M | (m) | (m) | (m) | Reported |
| 2022-06-30 | (m) | $5.10B | (m) | (m) | $561.53M | (m) | (m) | (m) | Reported |
| 2022-03-31 | (m) | $4.21B | (m) | (m) | $517.24M | (m) | (m) | (m) | Reported |
| 2021-12-31 | (m) | $3.62B | (m) | (m) | $497.31M | (m) | (m) | (m) | Reported |
| 2021-09-30 | (m) | $3.30B | (m) | (m) | $476.06M | (m) | (m) | (m) | Reported |
| 2021-06-30 | (m) | $2.84B | (m) | (m) | $476.65M | (m) | (m) | (m) | Reported |
| 2021-03-31 | (m) | $2.83B | (m) | (m) | $486.52M | (m) | (m) | (m) | Reported |
| 2020-12-31 | (m) | $1.95B | (m) | (m) | $584.47M | (m) | (m) | (m) | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | $710.80M | (m) | (m) | (m) | Reported |
| 2020-06-30 | (m) | (m) | (m) | (m) | $826.17M | (m) | (m) | (m) | Reported |
| 2020-03-31 | (m) | (m) | (m) | (m) | $937.77M | (m) | (m) | (m) | Reported |
| 2019-12-31 | (m) | (m) | (m) | (m) | $933.75M | (m) | (m) | (m) | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | $872.06M | (m) | (m) | (m) | Reported |
| 2019-06-30 | (m) | (m) | (m) | (m) | $788.97M | (m) | (m) | (m) | Reported |
| 2019-03-31 | (m) | (m) | (m) | (m) | $694.88M | (m) | (m) | (m) | Reported |
| 2018-12-31 | (m) | (m) | (m) | (m) | $606.43M | (m) | (m) | (m) | Reported |
| 2018-09-30 | (m) | (m) | (m) | (m) | $543.31M | (m) | (m) | (m) | Reported |
| 2018-06-30 | (m) | (m) | (m) | (m) | $505.78M | (m) | (m) | (m) | Reported |
| 2018-03-31 | (m) | (m) | (m) | (m) | $487.02M | (m) | (m) | (m) | Reported |
| 2017-12-31 | (m) | (m) | (m) | (m) | $460.87M | (m) | (m) | (m) | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | $433.69M | (m) | (m) | (m) | Reported |
| 2017-06-30 | (m) | (m) | (m) | (m) | $404.90M | (m) | (m) | (m) | Reported |
| 2017-03-31 | (m) | (m) | (m) | (m) | $390.43M | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | (m) | (m) | (m) | $373.42M | (m) | (m) | (m) | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | $359.01M | (m) | (m) | (m) | Reported |
| 2016-06-30 | (m) | (m) | (m) | (m) | $340.08M | (m) | (m) | (m) | Reported |
| 2016-03-31 | (m) | (m) | (m) | (m) | $321.26M | (m) | (m) | (m) | Reported |
| 2015-12-31 | (m) | (m) | (m) | (m) | $274.01M | (m) | (m) | (m) | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | $225.30M | (m) | (m) | (m) | Reported |
| 2015-06-30 | (m) | (m) | (m) | (m) | $181.05M | (m) | (m) | (m) | Reported |
| 2015-03-31 | (m) | (m) | (m) | (m) | $135.69M | (m) | (m) | (m) | Reported |
| 2014-12-31 | (m) | (m) | (m) | (m) | $140.71M | (m) | (m) | (m) | Reported |
| 2014-09-30 | (m) | (m) | (m) | (m) | $116.85M | (m) | (m) | (m) | Reported |
| 2014-06-30 | (m) | (m) | (m) | (m) | $86.98M | (m) | (m) | (m) | Reported |
| 2014-03-31 | (m) | (m) | (m) | (m) | $53.12M | (m) | (m) | (m) | Reported |
| 2013-12-31 | (m) | (m) | (m) | (m) | $15.02M | (m) | (m) | (m) | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $704.00K | (m) | (m) | (m) | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sabra Health Care REIT, Inc. (SBRA) | United States | $5.053B | 76.12 |
| KITE REALTY GROUP TRUST (KRG) | United States | $4.949B | 16.44 |
| OUTFRONT Media Inc. (OUT) | United States | $4.919B | 23.59 |
| STARWOOD PROPERTY TRUST, INC. (STWD) | United States | $5.312B | 22.96 |
| Phillips Edison & Company, Inc. (PECO) | United States | $4.777B | 36.48 |
| COUSINS PROPERTIES INC (CUZ) | United States | $4.690B | 698.71 |
| ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) | United States | $5.727B | 24.06 |
| RAYONIER INC (RYN) | United States | $5.734B | 13.37 |
| EPR PROPERTIES (EPR) | United States | $4.352B | 16.86 |
| AMERICOLD REALTY TRUST (COLD) | United States | $4.102B | -9.84 |